Evidence map›Paper›PMID 33322612›Full record

ArticleMolecules (Basel, Switzerland)2020

RETRACTED: Therapeutic Effects of Gallic Acid in Regulating Senescence and Diabetes; an In Vitro Study.

Mahban Rahimifard, Maryam Baeeri, Haji Bahadar, Shermineh Moini-Nodeh, Madiha Khalid, Hamed Haghi-Aminjan, Hossein Mohammadian, Mohammad Abdollahi

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. A Comprehensive Review of the Effects ofPreventive nutrition and food science · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Synergistic curative effects ofFrontiers in plant science · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Quality control, phytochemical profile, and biological activities ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mahban RahimifardToxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, 1417613151 Tehran, Iran.
Maryam BaeeriToxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, 1417613151 Tehran, Iran.
Haji BahadarInstitute of Paramedical Sciences, Khyber Medical University, 25120 Peshawar, Pakistan.
Shermineh Moini-NodehToxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, 1417613151 Tehran, Iran.
Madiha KhalidToxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, 1417613151 Tehran, Iran.ORCID 0000-0002-4538-1922
Hamed Haghi-AminjanPharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, 5618953141 Ardabil, Iran.
Hossein MohammadianToxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, 1417613151 Tehran, Iran.
Mohammad AbdollahiToxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, 1417613151 Tehran, Iran.ORCID 0000-0003-0123-1209
Tehran University of Medical Sciences · IRArdabil University of Medical Sciences · IRKhyber Medical University · PK

Funding

National Institute for Medical Research Development (NIMAD) 971478
6 · The paper itself

Abstract

Gallic acid (GA), a plant-derived ubiquitous secondary polyphenol metabolite, can be a useful dietary supplement. This in vitro study's primary purpose was to assess the anti-aging properties of GA using rat embryonic fibroblast (REF) cells, antidiabetic effects via pancreatic islet cells, and finally, elucidating the molecular mechanisms of this natural compound. REF and islet cells were isolated from fetuses and pancreas of rats, respectively. Then, several senescence-associated molecular and biochemical parameters, along with antidiabetic markers, were investigated. GA caused a significant decrease in the β-galactosidase activity and reduced inflammatory cytokines and oxidative stress markers in REF cells. GA reduced the G0/G1 phase in senescent REF cells that led cells to G2/M. Besides, GA improved the function of the β cells. Flow cytometry and spectrophotometric analysis showed that it reduces apoptosis via inhibiting caspase-9 activity. Taken together, based on the present findings, this polyphenol metabolite at low doses regulates different pathways of senescence and diabetes through its antioxidative stress potential and modulation of mitochondrial complexes activities.

Indexed as

Cellular SenescenceAnimalsAntioxidantsApoptosisbeta-GalactosidaseCaspase 9Cell CycleDiabetes MellitusFibroblastsFlow CytometryGallic AcidInflammationIn Vitro TechniquesIslets of LangerhansOxidative StressPolyphenolsAntioxidantsbeta-GalactosidaseCaspase 9Gallic AcidPolyphenolsantioxidantdiabetesgallic acidpolyphenolsecondary metabolitesenescence

Identifiers

PMID33322612
PMCPMC7763304
OpenAlexW3110672190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.